(Q77839269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

1 reference

J J Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Sonneborn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

N R Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M M Bern

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

F V Coco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E Dow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Oliynyk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

2347-2351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

Chemotherapy for advanced gastric cancer: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990601%2985%3A11%3C2347%3A%3AAID-CNCR8%3E3.0.CO%3B2-8

10.1002/(SICI)1097-0142(19990601)85:11<2347::AID-CNCR8>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10357404%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference